Review
doi: 10.1007/s11912-008-0013-z.Reversible posterior leukoencephalopathy syndrome in cancer
Affiliations
- PMID:18366965
- DOI: 10.1007/s11912-008-0013-z
Item in Clipboard
Review
Reversible posterior leukoencephalopathy syndrome in cancer
Christopher Vaughn et al. Curr Oncol Rep.2008 Jan.
Display options
Format
Display options
Format
Abstract
Reversible posterior leukoencephalopathy syndrome (RPLS) is a subacute neurological syndrome typically manifesting with headache, cortical blindness, and seizures. The syndrome is associated with risk factors such as malignant hypertension, eclampsia, and renal failure. Numerous case reports depict its occurrence in cancer patients. The direct causal relationship for the mechanism of RPLS in cancer patients has not yet been defined. Cytotoxic chemotherapy may cause direct endothelium damage, which would impact the blood-brain barrier. Chemotherapies also cause elevations in blood pressure; this is significant because RPLS onset may be solely related to hypertension. An increased number of case reports involving new targeted agents suggests that RPLS incidence may increase in the future. Agents such as bevacizumab and sorafenib have been implicated in new cases of RPLS.
Similar articles
- [Posterior Reversible Encephalopathy Syndrome Associated with Cancer Therapy].Mitsuya K, Nakasu Y, Hayashi N, Yasui H, Ikeda T, Kuji S, Onozawa Y, Endo M.Mitsuya K, et al.No Shinkei Geka. 2016 Mar;44(3):211-9. doi: 10.11477/mf.1436203259.No Shinkei Geka. 2016.PMID:26965062Japanese.
- Reversible posterior leukoencephalopathy syndrome.Moon JM, Chun BJ.Moon JM, et al.J Emerg Med. 2010 Apr;38(3):e1-4. doi: 10.1016/j.jemermed.2007.06.020. Epub 2007 Nov 19.J Emerg Med. 2010.PMID:18024064
- [Reversible posterior leukoencephalopathy syndrome (RPLS) associated with Wegener's granulomatosis: a case report and review of the literature].Onozawa R, Tsuboi Y, Obata T, Inoue H, Yamada T, Miyake K.Onozawa R, et al.Rinsho Shinkeigaku. 2012;52(8):567-70. doi: 10.5692/clinicalneurol.52.567.Rinsho Shinkeigaku. 2012.PMID:22975855Review.Japanese.
- Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.Wang W, Zhao LR, Lin XQ, Feng F.Wang W, et al.World J Gastroenterol. 2014 Jun 7;20(21):6691-7. doi: 10.3748/wjg.v20.i21.6691.World J Gastroenterol. 2014.PMID:24914397Free PMC article.
- Reversible posterior leukoencephalopathy syndrome due to adrenal pheochromocytoma: A case report and literature review.Han B, Li Y, Tang M, Wu S, Xu X.Han B, et al.Medicine (Baltimore). 2020 Jul 10;99(28):e20918. doi: 10.1097/MD.0000000000020918.Medicine (Baltimore). 2020.PMID:32664087Free PMC article.Review.
Cited by
- A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK.Schilder RJ, et al.Gynecol Oncol. 2013 Apr;129(1):86-91. doi: 10.1016/j.ygyno.2013.01.006. Epub 2013 Jan 13.Gynecol Oncol. 2013.PMID:23321064Free PMC article.Clinical Trial.
- Reversible posterior leukoencephalopathy induced by carboplatin and etoposide.Ryan SA, Maceneaney P, O'Reilly SP, Moylan EJ, Power DG.Ryan SA, et al.Med Oncol. 2012 Jun;29(2):1287-91. doi: 10.1007/s12032-011-9898-8. Epub 2011 Mar 10.Med Oncol. 2012.PMID:21390516
- Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab.Blaye C, Buy X, Gross-Goupil M, Vincent D, Jamet C, Sargos P, Culine S, Roubaud G.Blaye C, et al.Ther Adv Drug Saf. 2017 Apr;8(4):133-136. doi: 10.1177/2042098616682720. Epub 2017 Jan 16.Ther Adv Drug Saf. 2017.PMID:28439399Free PMC article.No abstract available.
- Reversible posterior leukoencephalopathy syndrome following apatinib for gastric cancer in an adult: A case report and a review of the literature.Lv Y, Zhang Y, Zhang J, Liang N, Liu F, Liu R.Lv Y, et al.Medicine (Baltimore). 2019 Nov;98(46):e17787. doi: 10.1097/MD.0000000000017787.Medicine (Baltimore). 2019.PMID:31725620Free PMC article.
- Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report.Egoryan G, Murguia-Fuentes R, Agab M, Abou-Ghanem N, Yanez-Bello MA, Pyakuryal B, Trelles-Garcia DP, Ibrahim R, Filipiuk D, Gidron A, Rodriguez-Nava G.Egoryan G, et al.J Med Case Rep. 2021 Apr 12;15(1):161. doi: 10.1186/s13256-021-02780-y.J Med Case Rep. 2021.PMID:33840384Free PMC article.